JCI Insight (Mar 2023)

Dissociation of sodium-chloride cotransporter expression and blood pressure during chronic high dietary potassium supplementation

  • Robert Little,
  • Sathish K. Murali,
  • Søren B. Poulsen,
  • Paul R. Grimm,
  • Adrienne Assmus,
  • Lei Cheng,
  • Jessica R. Ivy,
  • Ewout J. Hoorn,
  • Vladimir Matchkov,
  • Paul A. Welling,
  • Robert A. Fenton

Journal volume & issue
Vol. 8, no. 5

Abstract

Read online

Dietary potassium (K+) supplementation is associated with a lowering effect in blood pressure (BP), but not all studies agree. Here, we examined the effects of short- and long-term K+ supplementation on BP in mice, whether differences depend on the accompanying anion or the sodium (Na+) intake and molecular alterations in the kidney that may underlie BP changes. Relative to the control diet, BP was higher in mice fed a high NaCl (1.57% Na+) diet for 7 weeks or fed a K+-free diet for 2 weeks. BP was highest on a K+-free/high NaCl diet. Commensurate with increased abundance and phosphorylation of the thiazide sensitive sodium-chloride-cotransporter (NCC) on the K+-free/high NaCl diet, BP returned to normal with thiazides. Three weeks of a high K+ diet (5% K+) increased BP (predominantly during the night) independently of dietary Na+ or anion intake. Conversely, 4 days of KCl feeding reduced BP. Both feeding periods resulted in lower NCC levels but in increased levels of cleaved (active) α and γ subunits of the epithelial Na+ channel ENaC. The elevated BP after chronic K+ feeding was reduced by amiloride but not thiazide. Our results suggest that dietary K+ has an optimal threshold where it may be most effective for cardiovascular health.

Keywords